$KGKG
Kona Gold Beverage Inc Stock $kgkg

$kgkg Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040934 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue		$687.8K	$1.131M
YoY Change		-39.16%	107.3%
Cost Of Revenue		$501.1K	$873.3K
YoY Change		-42.63%	97.24%
Gross Profit		$186.7K	$257.2K
YoY Change		-27.4%	150.69%
Gross Profit Margin		27.15%	22.75%
Selling, General & Admin		$656.6K	$1.075M
YoY Change		-38.92%	42.18%
% of Gross Profit		351.61%	417.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$30.24K	$25.21K
YoY Change		19.95%	101.68%
% of Gross Profit		16.19%	9.8%
Operating Expenses		$656.6K	$1.075M
YoY Change		-38.92%	42.18%
Operating Profit		-$469.9K	-$817.8K
YoY Change		-42.55%	25.14%
Interest Expense		$176.4K	$253.9K
YoY Change		-30.5%	1380.29%
% of Operating Profit
Other Income/Expense, Net		$2.403K	-$374.2K
YoY Change		-100.64%
Pretax Income		-$518.1K	-$1.192M
YoY Change		-56.55%	-46.07%
Income Tax			-$430.00
% Of Pretax Income
Net Earnings		-$518.1K	-$1.192M
YoY Change		-56.54%	-46.56%
Net Earnings / Revenue		-75.33%	-105.44%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share		$0.00	-$677.10
COMMON SHARES
Basic Shares Outstanding	2.453B shares	2.295B shares	1.781B shares
Diluted Shares Outstanding		2.340B shares	1.761B shares

Balance Sheet

Concept	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$369.9K	$270.8K
YoY Change	36.61%	-50.45%
Cash & Equivalents	$369.9K	$270.8K
Short-Term Investments
Other Short-Term Assets	$50.31K	$17.90K
YoY Change	181.07%	174.64%
Inventory	$334.0K	$1.008M
Prepaid Expenses
Receivables	-$120.3K	$56.11K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$633.9K	$1.353M
YoY Change	-53.13%	-13.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$279.1K	$370.5K
YoY Change	-24.66%	31.84%
Goodwill
YoY Change
Intangibles	$47.01K	$68.64K
YoY Change	-31.52%
Long-Term Investments
YoY Change
Other Assets	$7.100K	$15.13K
YoY Change	-53.07%	-99.44%
Total Long-Term Assets	$767.6K	$1.278M
YoY Change	-39.93%	-55.37%
TOTAL ASSETS
Total Short-Term Assets	$633.9K	$1.353M
Total Long-Term Assets	$767.6K	$1.278M
Total Assets	$1.402M	$2.631M
YoY Change	-46.72%	-40.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.849M	$1.041M
YoY Change	77.62%	405.05%
Accrued Expenses	$503.3K	$376.8K
YoY Change	33.6%	105.03%
Deferred Revenue
YoY Change
Short-Term Debt	$663.0K	$530.6K
YoY Change	24.95%	-77.89%
Long-Term Debt Due	$2.732M	$2.266M
YoY Change	20.55%	64840.11%
Total Short-Term Liabilities	$6.400M	$5.231M
YoY Change	22.36%	-10.45%
LONG-TERM LIABILITIES
Long-Term Debt	$56.84K	$71.75K
YoY Change	-20.78%	-97.1%
Other Long-Term Liabilities	$297.0K
YoY Change
Total Long-Term Liabilities	$353.8K	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.400M	$5.231M
Total Long-Term Liabilities	$353.8K	$0.00
Total Liabilities	$6.754M	$5.980M
YoY Change	12.94%	-36.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.26M	-$22.44M
YoY Change	21.46%	63.77%
Common Stock	$23.82K	$18.07K
YoY Change	31.88%	104.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.353M	-$3.350M
YoY Change
Total Liabilities & Shareholders Equity	$1.402M	$2.631M
YoY Change	-46.72%	-40.54%

Cashflow Statement

Concept	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$518.1K	-$1.192M
YoY Change	-56.54%	-46.56%
Depreciation, Depletion And Amortization	$30.24K	$25.21K
YoY Change	19.95%	101.68%
Cash From Operating Activities	$556.5K	-$529.2K
YoY Change	-205.16%	-25.58%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$18.75K
YoY Change	-100.0%	-84.33%
Acquisitions
YoY Change
Other Investing Activities	$8.480K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$8.480K	-$18.75K
YoY Change	-145.23%	-84.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-292.2K	812.6K
YoY Change	-135.96%	-36.54%
NET CHANGE
Cash From Operating Activities	556.5K	-529.2K
Cash From Investing Activities	8.480K	-18.75K
Cash From Financing Activities	-292.2K	812.6K
Net Change In Cash	272.8K	264.6K
YoY Change	3.09%	-41.46%
FREE CASH FLOW
Cash From Operating Activities	$556.5K	-$529.2K
Capital Expenditures	$0.00	-$18.75K
Free Cash Flow	$556.5K	-$510.5K
YoY Change	-209.03%	-13.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001802546
CY2022Q3	KGKG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
	KGKG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
CY2022Q3	KGKG	Financing Cost Expense FinancingCostExpense		usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	KGKG	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	KGKG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
	KGKG	Loss On Termination Of Operating Lease LossOnTerminationOfOperatingLease		usd
	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities		usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	KGKG	Increase Decrease In Deposit IncreaseDecreaseInDeposit		usd
	KGKG	Payments For Proceeds From Purchase Of Purchase Property Plant And Equipment PaymentsForProceedsFromPurchaseOfPurchasePropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	KGKG	Termination Of Right Of Use Asset TerminationOfRightOfUseAsset		usd
	KGKG	Termination Of Operating Lease Liabilitty TerminationOfOperatingLeaseLiabilitty		usd
	KGKG	Note Payable Issued On Termination Of Lease Liability NotePayableIssuedOnTerminationOfLeaseLiability		usd
	KGKG	Vendor Line Of Credit Reclassified To Notes Payable VendorLineOfCreditReclassifiedToNotesPayable		usd
	KGKG	Vendor Line Of Credit Reclassified To Notes Payable VendorLineOfCreditReclassifiedToNotesPayable		usd
	KGKG	Fair Value Of Warrants Issued Upon Issuance Of Convertible Notes FairValueOfWarrantsIssuedUponIssuanceOfConvertibleNotes		usd
	KGKG	Derivative Liability Recorded On Issuance Of Convertible Notes DerivativeLiabilityRecordedOnIssuanceOfConvertibleNotes		usd
	KGKG	Note Payable On Vehicle Purchase NotePayableOnVehiclePurchase		usd
CY2023Q3	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks		usd
CY2023Q3	KGKG	Lessee Operating Lease Liability Payments Due Year Four And Thereafter LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter		usd
	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56230
	dei	Entity Registrant Name EntityRegistrantName	KONA GOLD BEVERAGE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1915692
	dei	Entity Address Address Line1 EntityAddressAddressLine1	746 North Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32934
	dei	City Area Code CityAreaCode	(844)
	dei	Local Phone Number LocalPhoneNumber	714-2224
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	KGKG
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2453312419	shares
CY2023Q3	us-gaap	Cash Cash	369931	usd
CY2022Q4	us-gaap	Cash Cash	39788	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	154224	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	145579	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	-120288	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	79529	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	333990	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	859179	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	50306	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45262	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	633939	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1023758	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	279134	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348064	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	136500	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	434402	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	762464	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47006	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	66201	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7100	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2023Q3	us-gaap	Assets Assets	1401581	usd
CY2022Q4	us-gaap	Assets Assets	2215612	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1849053	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1379227	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	325279	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	137083	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	83973	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	218481	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	652788	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	659550	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	178074	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209685	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	662974	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	411060	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6400432	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5294755	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	56835	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57055	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	296983	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	629197	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6754250	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5981007	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5702000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5702000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	989000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	989000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2382423530	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2382423530	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2000276378	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2000276378	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	23824	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20003	usd
CY2023Q3	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	169998860	shares
CY2022Q4	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	169998860	shares
CY2023Q3	KGKG	Common Stock Issuable CommonStockIssuable	1386489	usd
CY2022Q4	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20495431	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18441303	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27258423	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23613208	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5352669	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1401581	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2215612	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	687797	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1130546	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2892213	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3299075	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	501056	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	873319	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2230601	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2608712	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	186741	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	257227	usd
	us-gaap	Gross Profit GrossProfit	661612	usd
	us-gaap	Gross Profit GrossProfit	690363	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	656607	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1075044	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2858287	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3045895	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-469866	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-817817	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2196675	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2355532	usd
CY2023Q3	KGKG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	42151	usd
	KGKG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	42151	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	345619	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	345619	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	176434	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	253855	usd
	us-gaap	Interest Expense InterestExpense	779396	usd
	us-gaap	Interest Expense InterestExpense	867209	usd
CY2023Q3	KGKG	Financing Cost Expense FinancingCostExpense	5173	usd
	KGKG	Financing Cost Expense FinancingCostExpense	294173	usd
	KGKG	Financing Cost Expense FinancingCostExpense	260000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	148000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1523000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-256792	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-268810	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-770312	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1141850	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2403	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	425	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7571	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5447	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-518092	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1192057	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3645215	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6142144	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2340337120	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2340337120	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1760650640	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1760650640	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2156953058	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2156953058	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1580864982	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1580864982	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5236830	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	315000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	78673	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8580	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-518092	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5352669	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1203751	usd
	KGKG	Stock Issued During Period Value For Financing Costs StockIssuedDuringPeriodValueForFinancingCosts	126000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	78673	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	296250	usd
	KGKG	Adjustments To Additional Paid In Capital Warrants Issued For Financing Costs AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedForFinancingCosts	163000	usd
	KGKG	Stock Issued During Period Value Preferred Stock Conversion To Common Stock StockIssuedDuringPeriodValuePreferredStockConversionToCommonStock	185000	usd
	KGKG	Adjustments To Additional Paid In Capital Warrant Related To Services Rendered AdjustmentsToAdditionalPaidInCapitalWarrantRelatedToServicesRendered	5269	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3645215	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5352669	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2991280	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	610683	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	223000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1192057	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3349654	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6469848	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	135000	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	8500	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	304000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6142144	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3349654	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3349654	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3645215	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6142144	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	70353	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67018	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8645	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	35	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	79792	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	143320	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	631542	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	702675	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10719	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7316	usd
	KGKG	Preferred Stock Issued For Common Stock Issuable PreferredStockIssuedForCommonStockIssuable	-185000	usd
	KGKG	Fair Value Of Warrants Issued For Financing Costs FairValueOfWarrantsIssuedForFinancingCosts	367673	usd
	KGKG	Fair Value Of Warrants Issued For Services FairValueOfWarrantsIssuedForServices	5269	usd
	KGKG	Fair Value Of Warrants Issued For Services FairValueOfWarrantsIssuedForServices	260000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1423	usd
	KGKG	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	42151	usd
	KGKG	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	728056	usd
	KGKG	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	1141855	usd
	KGKG	Loss On Termination Of Operating Lease LossOnTerminationOfOperatingLease	9601	usd
	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities	-1523000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8500	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-191172	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	40147	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-525188	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	433068	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-278707	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5044	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-12475	usd
	KGKG	Increase Decrease In Deposit IncreaseDecreaseInDeposit	-1775	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	759235	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	645765	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	188195	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-170000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-97106	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-153890	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28724	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2148583	usd
	KGKG	Payments For Proceeds From Purchase Of Purchase Property Plant And Equipment PaymentsForProceedsFromPurchaseOfPurchasePropertyPlantAndEquipment	42923	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8475	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8475	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42923	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	222000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	260000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4500	usd
	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	6762	usd
	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	11446	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5594	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3798	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	800930	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	542000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1251656	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5598	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	727974	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	981816	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	350392	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1758474	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	330143	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-433032	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39788	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	703825	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	369931	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	270793	usd
	us-gaap	Interest Paid Net InterestPaidNet	14947	usd
	us-gaap	Interest Paid Net InterestPaidNet	533	usd
	us-gaap	Stock Issued1 StockIssued1	135000	usd
	KGKG	Termination Of Right Of Use Asset TerminationOfRightOfUseAsset	248270	usd
	KGKG	Termination Of Operating Lease Liabilitty TerminationOfOperatingLeaseLiabilitty	261125	usd
	KGKG	Note Payable Issued On Termination Of Lease Liability NotePayableIssuedOnTerminationOfLeaseLiability	16206	usd
	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	315000	usd
	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	6469848	usd
	KGKG	Fair Value Of Warrants Issued Upon Issuance Of Convertible Notes FairValueOfWarrantsIssuedUponIssuanceOfConvertibleNotes	296250	usd
	KGKG	Derivative Liability Recorded On Issuance Of Convertible Notes DerivativeLiabilityRecordedOnIssuanceOfConvertibleNotes	680000	usd
	KGKG	Note Payable On Vehicle Purchase NotePayableOnVehiclePurchase	46576	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3645215	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28724	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5352669	usd
CY2023Q3	us-gaap	Cash Cash	369931	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zOpMyhlMlf09" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zJjGBsejrXhe">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	154224	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	145579	usd
	KGKG	Sales Percentage SalesPercentage	0.03	pure
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	687797	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1130546	usd
CY2023Q3	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.39	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2892213	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3299075	usd
	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.12	pure
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	687797	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1130546	usd
CY2023Q3	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.39	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2892213	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3299075	usd
	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.12	pure
	us-gaap	Advertising Expense AdvertisingExpense	98351	usd
	us-gaap	Advertising Expense AdvertisingExpense	118807	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2357094737	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	278333333	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2357094737	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	278333333	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zhck2IXJrA9i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zohgfDkSARm4">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20230930_zb4uZmqUWqk2" title="Cash FDIC insured amount">250,000</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the three and nine months ended September 30, 2023 and 2022, no customers accounted for more than <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zBifywNilRri" title="Concentration risk, percentage"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z0RV4X9nNeU3" title="Concentration risk, percentage"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_znJPZtNW6sh4" title="Concentration risk, percentage"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zX0nbvrPUKR4" title="Concentration risk, percentage">10</span></span></span></span>% of gross sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of September 30, 2023, the Company had accounts receivable from two customers that comprised <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zD1W3nJYuSy5" title="Concentration risk percentage">12</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zuP5Ee5qNbid" title="Concentration risk percentage">10</span>%, respectively, of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers that comprised<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7j9mzLQnvv2" title="Concentration risk percentage"> 27</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zZi2O4qLwkfd" title="Concentration risk percentage">20</span>%, respectively, of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Co-Packers. </i>The raw materials used in the production of the Company’s products are obtained by the Company’s co-packers and consist primarily of materials such as the flavors, caffeine, sugars or sucralose, taurine, vitamins, CBD, and hemp seed protein contained in its beverages, the bottles in which its beverages are packaged, and the labeling on the outside of its beverages. These principal raw materials are subject to price and availability fluctuations. The Company currently relies on a few key co-packers, which in turn rely on a few key suppliers. The Company continually endeavors to have back-up co-packers, which co-packers would in turn depend on their third-party suppliers to supply certain of the flavors and concentrates that are used in the Company’s beverages. The Company is also dependent on these co-packers to negotiate arrangements with their existing suppliers that would enable the Company to obtain access to certain of such concentrates or flavor formulas under certain extraordinary circumstances. Additionally, in a limited number of cases, the Company’s co-packers may have contractual restrictions with their suppliers or the Company’s co-packers may need to obtain regulatory approvals and licenses that may limit the co-packers’ ability to enter into agreements with alternative suppliers. Contractual restrictions in the agreements the Company has with certain distributors may also limit the Company’s ability to enter into agreements with alternative distributors. The Company believes that a satisfactory supply of co-packers will continue to be available at competitive prices, although there can be no assurance in this regard. With respect to Gold Leaf’s operations, the Company continually endeavors to contract with additional beverage vendors to ensure the Company has adequate inventory. The Company believes that a satisfactory supply of vendors will continue to be available at competitive prices, although there can be no assurance in this regard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended September 30, 2023, the Company’s largest three vendors accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zGfqwkPh25z8">55</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zlg9q14bvst5">12</span>%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_z3wKoyYlixzh">10</span>% of all purchases, respectively. During the year ended December 31, 2022, the Company’s largest one vendor accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zmh7RVPtiUOj">34</span>% of all purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of September 30, 2023, two vendors accounted for more than <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--TwoVendorMember_z4iRnyTzYcYh" title="Concentration risk, percentage">10</span>% the total accounts payable. The Company’s largest two vendors accounted for<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zXfH8kw7pzh1"> 29</span>%, and<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorTwoMember_za7rn91X8dp9"> 17</span>% of the total accounts payable, respectively. As of December 31, 2022, two vendors accounted for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--TwoVendorMember_zqHE9YrZD5O8" title="Concentration risk, percentage">10</span>% the total accounts payable. The Company’s largest two vendors accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zHM5SfTmn377">31</span>%, and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zG0nvbtwpap3">18</span>% of the total accounts payable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	KGKG	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	12262	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47006	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	500000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	70915	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	198605	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	263075	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	660574	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	333990	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	859179	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1044072	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	988035	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	544575	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	543152	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	265441	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	195088	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	279134	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348064	usd
CY2023Q3	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	81750	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2022Q4	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34744	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28901	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47006	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68639	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7316	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7316	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2044	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8175	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8175	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8175	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	8175	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	83973	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	218481	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	960099	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	769554	usd
CY2023Q3	KGKG	Notes Payable Current Portion NotesPayableCurrentPortion	903264	usd
CY2022Q4	KGKG	Notes Payable Current Portion NotesPayableCurrentPortion	712499	usd
CY2023Q3	KGKG	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	56835	usd
CY2022Q4	KGKG	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	57055	usd
	us-gaap	Lease Cost LeaseCost	136726	usd
	us-gaap	Lease Cost LeaseCost	152841	usd
CY2022Q4	KGKG	Lease Liabilities LeaseLiabilities	838882	usd
CY2022Q4	KGKG	Finance Lease Liabilities FinanceLeaseLiabilities	17824	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	821058	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5594	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	97106	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	261125	usd
CY2023Q3	KGKG	Lease Liabilities LeaseLiabilities	475057	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	178074	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	296983	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M21D
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	57521	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	197491	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	170059	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	113790	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	538861	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	63804	usd
CY2023Q3	KGKG	Present Value Of Net Minimum Lease Payments PresentValueOfNetMinimumLeasePayments	475057	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	178074	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	296983	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	989000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2382423530	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2382423530	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2000276378	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2000276378	shares
CY2016Q4	KGKG	Employement Agreement Description EmployementAgreementDescription	Immediately, Mr. Clark decided to defer receipt of 80,000,000 of such shares; thus leaving 120,000,000 shares of the Common Stock to be issued to him
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	278333333	shares
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.0223
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	257689945	shares
	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0038
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	67164179	shares
	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0149
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	20000000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	448859099	shares
CY2023Q3	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.0137
CY2023Q3	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	448859099	shares
CY2023Q3	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Weighted Average Exercisable Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsWeightedAverageExercisablePrice	0.0137
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	448859099	shares
CY2023Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y2M1D
	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Outstanding Non Options Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNonOptionsWeightedAverageExercisePrice	0.0146
CY2023Q3	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	448859099	shares
CY2023Q3	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	0.0146
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0022

Files In Submission

Name	View Source	Status
0001493152-23-040934-index-headers.html	Edgar Link	pending
0001493152-23-040934-index.html	Edgar Link	pending
0001493152-23-040934.txt	Edgar Link	pending
0001493152-23-040934-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kgkg-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
kgkg-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
kgkg-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kgkg-20230930_cal.xml	Edgar Link	unprocessable
kgkg-20230930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KGKG
Kona Gold Beverage Inc Stock $kgkg

2023 Q4 Form 10-Q Financial Statement

#000149315223040934 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG Kona Gold Beverage Inc Stock $kgkg

2023 Q4 Form 10-Q Financial Statement

#000149315223040934 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG
Kona Gold Beverage Inc Stock $kgkg